Akums Drugs Montelukast Sodium, Bilastine FDC gets CDSCO panel okay for phase 3 trial Medical Dialogues Team18 Jun 2021 11:15 AM ISTNew Delhi: The Subject Expert Committee functional under the Central Drugs Standard Control Organization (CDSCO) has given its clearance to Akums...
Oral Montelukast Reduces Risk of Diabetic Retinopathy: ARVO 2021 Dr Kartikeya Kohli9 Jun 2021 9:00 AM ISTChronic inflammation and oxidative stress are critical components in the pathogenic cascade of early diabetic retinopathy, characterized by neuronal...
Montelukast not linked to increased risk of ADHD in kids with Asthma: Study Dr. Nandita Mohan7 Dec 2020 8:15 AM ISTAccording to a nationwide population-based cohort study, researchers have revealed that asthma children treated with montelukast were not at an...
Montelukast must have boxed warning for neuropsychiatric events risk insists FDA Dr. Kamal Kant Kohli5 March 2020 7:33 AM ISTThe U.S. Food and Drug Administration has issued instructions to manufacturers of montelukas to strengthen an existing warning about the risk of...
